排序方式： 共有29条查询结果，搜索用时 15 毫秒
11.
12.
GISELLE HOSGOOD BVSC MS MACVSC DAVID L. BONE DVM DiplomateACvs WILLIAM D. VORHEES III PhD WILLIE M. REED DVM PhD DiplomateACVP 《Veterinary surgery : VS》1989,18(2):110-113
Splenectomy was performed in 15 crossbred dogs; hilar vessel ligation was used in eight dogs (group 1) and splenic and short gastric artery ligation were used in seven (group 2). Blood flow to six sites along the greater and lesser curvatures of the stomach was recorded with radioactive tracer microspheres. A significantly higher blood flow was recorded in group 2 for the site supplied by the right gastroepiploic artery (p = 0.0441). There was no difference between the groups for the site supplied by the left gastroepiploic and short gastric arteries. Histologically, there was no difference in gastric tissue samples from four sites. Splenic and short gastric artery ligation did not compromise stomach blood flow or the integrity of the stomach wall, and may be superior for splenectomy because of its relative simplicity and potentially shorter operative time. 相似文献
13.
GORDON W. BRUMBAUGH WILLIAM P. THOMAS† L. REED ENOS JIRO J. KANEKO‡ 《Journal of veterinary pharmacology and therapeutics》1983,6(3):163-172
Digoxin was administered orally and intravenously to seven healthy adult mares and geldings in two separate trials. At a dose of 44 microgram digoxin/kg body weight, the oral study was characterized by an absorption phase with a mean (+/- 1 standard deviation) peak serum digoxin concentration of 2.21 ng/ml (+/- 0.45) at a mean of 2.29 h (+/- 1.52) after administration. A second rise in serum digoxin concentration started about 6-8 h after administration and extended to about 20 h after administration. The mean bioavailability (F) was 23.38% (+/- 5.96). At a dose of 22 microgram digoxin/kg body weight, the intravenous study was characterized by a two-compartment model with the following mean pharmacokinetic measurements: distribution rate constant (alpha), 1.391 h-1 (+/- 0.1909); zero-time serum digoxin concentration determined from the distribution phase (A), 21.247 ng/ml (+/- 5.6614); elimination rate constant (beta), 0.0409 h-1 (+/- 0.0069); zero-time serum digoxin concentration determined from the elimination phase (B), 3.82 ng/ml (+/- 0.433); apparent specific volume of distribution uncorrected for protein binding (Vd beta), 5.003 l/kg (+/- 0.5177). The mean beta corresponded to a biological half-life (T1/2 beta) of 16.9 h. Based upon results of this study, theoretically achievable steady-state serum digoxin concentrations were calculated for maintenance doses given by oral and intravenous routes of administration with appropriate two-compartment, multiple-dose formulae. Loading doses were also calculated for each route. It is the opinion of the authors that the oral route of administration of digoxin is effective in the horse and may preclude the potential risks posed by the high serum digoxin concentrations immediately following intravenous administration. 相似文献
14.
Reasons for performing study: The use of computer tomography (CT) and contrast‐enhanced CT (CCT) to image the head is common. However, the validity of CT as a neurodiagnostic indicator of intracranial diseases in horses is unknown. Objective: To define the validity of CT and CCT in horses with suspected intracranial disorders. Methods: The validity of CT imaging was estimated by comparing clinical, clinicopathological and histopathological findings to CT findings in 15 horses presented for intracranial disorders, for which pre‐ and post contrast CT images and post mortem examination of the brain and skull were reviewed. Post mortem examination (gross and histopathological examination) was considered as the gold standard; and sensitivity, specificity, predictive values, likelihood ratios, and pre‐ and post test probabilities were calculated. Results: All horses had abnormal neurological examinations on admission. Computer tomography imaging identified intracranial lesions in 8 horses, and included masses (oligodendroglioma, adenocarcinoma and cholesterinic granulomas), acute haemorrhage and skull fractures. Computer tomography imaging failed to identify intracranial lesions in 6 cases, which included meningitis, meningoencephalitis and nonacute haemorrhage. Lesions not recognised by CT were also not evident on gross examination but were identified by histopathological examination of the brain. Post mortem examination of the brain and skull was unremarkable in one horse, for which cranial CT imaging was normal (specificity, 100%). Therefore, the odds of having an intracranial lesion after an abnormal CT were very high. In contrast, there was a moderate sensitivity (57.1%, 95% confidence interval: 29.6–81.2). Conclusions and potential relevance: CT was an excellent neurodiagnostic tool in identifying skull fractures, intracranial space‐occupying lesions (e.g. neoplasia) and acute haemorrhage and allows to rule in intracranial disorders. However, CT showed limited sensitivity in identifying inflammatory disorders and small parenchymal lesions in the equine brain, which was not further detectable after contrast administration. 相似文献
15.
16.
17.
B. S. BARR B. M. WALDRIDGE P. R. MORRESEY S. M. REED C. CLARK R. BELGRAVE J. M. DONECKER D. J. WEIGEL 《Equine veterinary journal》2013,45(2):154-158
Reasons for performing study: Although antimicrobial‐associated diarrhoea (AAD) is the most frequently observed adverse effect of antimicrobial therapy in horses, few multicentred studies on the prevalence of AAD have been performed. Objectives: To determine the prevalence of AAD in horses that developed diarrhoea after antimicrobial treatment for nondiarrhoeic conditions and identify the antimicrobials used. Methods: The 2009 database of 3 referral hospitals was searched to identify nonhospitalised horses (weanling age or older) treated with antimicrobials for nongastrointestinal conditions. Horses with these criteria that presented with diarrhoea during 2009 were included in the study. Additional information, including antimicrobial administered and results of faecal pathogen testing, was gathered on each hospitalised case. Results: Of the 5251 horses treated with antimicrobials for nongastrointestinal signs, 32 were diagnosed with probable AAD, a prevalence of 0.6% (95% confidence interval: 0.43–0.86%). The AAD‐diagnosed horses had an 18.8% (6/32) mortality rate. Horses with AAD had been treated for an average of 4.2 days. The most frequently used antimicrobials in horses with AAD were gentamicin in combination with penicillin (n = 7), enrofloxacin (n = 7) and doxycycline (n = 4). Clostridium difficile was identified in faecal samples from 4 horses, 2 of which died and Salmonella from 3 horses. Conclusions: Results indicated that the prevalence of AAD is low. Any antimicrobial class commonly used in equine practice is a potential cause of equine AAD. Other risk factors, such as opportunistic enteropathogens, may play a part in the development of diarrhoea secondary to antimicrobial usage. Potential relevance: Although the risk of equine AAD is low, this sequela of antimicrobial treatment is possible especially when opportunistic enteropathogens or other risk factors are present. Because drugs from any antimicrobial class can be potentially involved in AAD, clinicians have additional incentive to ensure the judicious use of antimicrobial agents. 相似文献
18.
19.
Objective: To determine the efficacy of a novel copper based footbath preparation (CHF-1020) for treatment of ovine footrot during the spread period.
Design: A series of field trials with treated and control groups run together.
Animals: Mobs of at least 125 sheep on each of six properties in southern New South Wales with equal numbers of controls.
Procedure: Sheep of group A were treated after minimal paring by making them stand in CHF-1020 for 15 minutes. Treatment was undertaken at intervals throughout the period of the trials (14 September to 17 December 1993). Group A sheep were run on the same pasture as those from group B (untreated sheep).
Results: The percentage of sheep exhibiting clinical signs of ovine footrot at the start of the trial ranged from 35 to 88% at score 3 or higher, using a 0 to 5 footscoring system. During the trial, the percentage of infected sheep (greater or equal to score 2) in group B increased and ranged from 40 to 90%. The level of infected sheep in group A on each property was reduced progressively to 1 to 16%. Cure rates of 45 to 94% were achieved, with the lowest rate being on a property with a metal footbath. The next lowest cure rate was 73%. Results indicated that treatment should be undertaken at 2-weekly intervals while spread continues. Treated sheep can be returned to contaminated pastures.
Conclusion: CHF-1020 is effective during the spread period and can be used for the progressive eradication of ovine footrot. 相似文献
Design: A series of field trials with treated and control groups run together.
Animals: Mobs of at least 125 sheep on each of six properties in southern New South Wales with equal numbers of controls.
Procedure: Sheep of group A were treated after minimal paring by making them stand in CHF-1020 for 15 minutes. Treatment was undertaken at intervals throughout the period of the trials (14 September to 17 December 1993). Group A sheep were run on the same pasture as those from group B (untreated sheep).
Results: The percentage of sheep exhibiting clinical signs of ovine footrot at the start of the trial ranged from 35 to 88% at score 3 or higher, using a 0 to 5 footscoring system. During the trial, the percentage of infected sheep (greater or equal to score 2) in group B increased and ranged from 40 to 90%. The level of infected sheep in group A on each property was reduced progressively to 1 to 16%. Cure rates of 45 to 94% were achieved, with the lowest rate being on a property with a metal footbath. The next lowest cure rate was 73%. Results indicated that treatment should be undertaken at 2-weekly intervals while spread continues. Treated sheep can be returned to contaminated pastures.
Conclusion: CHF-1020 is effective during the spread period and can be used for the progressive eradication of ovine footrot. 相似文献
20.
R.K. REED 《Fisheries Oceanography》1995,4(4):317-323
Data from 1971 to 1993 are used to examine characteristics and variability of the subsurface temperature maximum in the Aleutian Basin of the Bering Sea. The temperature of this feature varies from ∼3.5C to 4.6C at depths of ∼150–400 m, and sigma-t density is usually in the range 26.6–26.9. The variability is caused mainly by the absence or presence of inflow of warm, low-density Alaskan Stream water through Amukta Pass. Thus the environment offish stocks is far from uniform. 相似文献